H.R. 10887House bill · 119th CongressIn committee

Protecting Consumer Access to Generic Drugs Act of 2026

Sponsored bySeth MagazinerD-RI-2Introduced Oct 22, 2026Full text on congress.gov ↗

Latest action (Oct 22, 2026) — on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

What it does

not written yet

The Congressional Research Service writes the plain-English summary for every bill, usually a few weeks after it's introduced. This one doesn't have one yet. It will appear here when it does.

In the meantime the most reliable description is the bill's own official title, which is the heading above — written by its sponsor, and the only account of the bill that exists at this stage. The full text is on congress.gov ↗

We don't write our own summaries. Everything else on this site links back to a record you can check, and a description of a bill that came from us rather than from the bill would be the one thing here that didn't — on the page that asks you to take a position on it.

Discussion

2 comments

Sign in to join the discussion and put your vote on the record.

Sort
6
petra.lindqvistDemoTX-19voted Nay23h ago
My hesitation is the absence of a sunset. Authorities that never expire never get re-examined either. The floor version may not be this version, which is the usual problem.
1
roy_gazetteDemoMT-1voted Nay16h ago
This is unglamorous plumbing, and unglamorous plumbing is usually what matters. Yes from me. The committee report would settle it either way.
Your position on H.R. 10887No positions yet